A detailed history of Peak6 Investments LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Peak6 Investments LLC holds 223,400 shares of BNTX stock, worth $25.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
223,400
Previous 35,600 527.53%
Holding current value
$25.3 Million
Previous $2.86 Million 827.73%
% of portfolio
0.06%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$80.36 - $102.87 $917,309 - $1.17 Million
11,415 Added 180.19%
17,750 $1.43 Million
Q1 2024

May 14, 2024

SELL
$88.96 - $112.35 $6.01 Million - $7.59 Million
-67,599 Reduced 91.43%
6,335 $584,000
Q4 2023

Feb 13, 2024

BUY
$90.91 - $112.75 $2.87 Million - $3.56 Million
31,556 Added 74.46%
73,934 $7.8 Million
Q3 2023

Nov 13, 2023

BUY
$98.5 - $125.08 $4.17 Million - $5.3 Million
42,378 New
42,378 $4.6 Million
Q4 2022

Feb 10, 2023

BUY
$118.43 - $186.05 $3.73 Million - $5.85 Million
31,467 Added 87.88%
67,273 $10.1 Million
Q3 2022

Nov 14, 2022

BUY
$127.65 - $183.11 $4.09 Million - $5.87 Million
32,057 Added 855.08%
35,806 $4.83 Million
Q2 2022

Aug 12, 2022

SELL
$123.25 - $186.24 $10.1 Million - $15.2 Million
-81,658 Reduced 95.61%
3,749 $559,000
Q1 2022

May 13, 2022

SELL
$126.25 - $231.85 $248,965 - $457,208
-1,972 Reduced 2.26%
85,407 $14.6 Million
Q4 2021

Feb 11, 2022

SELL
$216.64 - $362.52 $27 Million - $45.3 Million
-124,851 Reduced 58.83%
87,379 $22.5 Million
Q3 2021

Nov 12, 2021

BUY
$205.93 - $447.23 $40.6 Million - $88.3 Million
197,349 Added 1326.18%
212,230 $57.9 Million
Q2 2021

Aug 13, 2021

BUY
$113.32 - $241.49 $953,247 - $2.03 Million
8,412 Added 130.04%
14,881 $3.33 Million
Q1 2021

May 14, 2021

BUY
$85.73 - $119.5 $554,587 - $773,045
6,469 New
6,469 $706,000

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $27.4B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.